Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01490086
Show Display Options
Rank Status Study
1 Completed RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
Conditions: Acute Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: RP5063;   Drug: placebo;   Drug: aripiprazole

Indicates status has not been verified in more than two years